ENTRY       D01148                      Drug
NAME        Tolterodine tartrate (JAN/USP);
            Detrol (TN);
            Detrusitol (TN)
PRODUCT     DETROL (PHARMACIA & UPJOHN COMPANY LLC)
            DETROL LA (Pharmacia and Upjohn Company LLC)
  GENERIC   TOLTERODINE TARTRATE (A-S Medication Solutions)
            TOLTERODINE TARTRATE (A-S Medication Solutions)
            TOLTERODINE TARTRATE (ANI Pharmaceuticals)
            TOLTERODINE TARTRATE (Ajanta Pharma USA)
            TOLTERODINE TARTRATE (American Health Packaging)
            TOLTERODINE TARTRATE (Athem LLC)
            TOLTERODINE TARTRATE (Camber Pharmaceuticals)
            TOLTERODINE TARTRATE (Camber Pharmaceuticals)
            TOLTERODINE TARTRATE (Drug Ocean LLC)
            TOLTERODINE TARTRATE (Golden State Medical Supply)
            TOLTERODINE TARTRATE (Greenstone LLC)
            TOLTERODINE TARTRATE (Macleods Pharmaceuticals Limited)
            TOLTERODINE TARTRATE (Major Pharmaceuticals)
            TOLTERODINE TARTRATE (Marlex Pharmaceuticals)
            TOLTERODINE TARTRATE (Proficient Rx LP)
            TOLTERODINE TARTRATE (Rising Pharma Holdings)
            TOLTERODINE TARTRATE (Slate Run Pharmaceuticals)
            TOLTERODINE TARTRATE (Teva Pharmaceuticals USA)
            TOLTERODINE TARTRATE (Teva Pharmaceuticals USA)
            TOLTERODINE TARTRATE (Torrent Pharmaceuticals Limited)
            TOLTERODINE TARTRATE (Unichem Pharmaceuticals (USA))
            TOLTERODINE TARTRATE EXTENDED RELEASE (Greenstone LLC)
FORMULA     C22H31NO. C4H6O6
EXACT_MASS  475.257
MOL_WEIGHT  475.5745
CLASS       Neuropsychiatric agent
             DG01491  Muscarinic cholinergic receptor antagonist
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2590
            ATC code: G04BD07
            Chemical structure group: DG00480
            Product (DG00480): D01148<JP/US>
EFFICACY    Overactive bladder agent, Muscarinic acetylcholine receptor antagonist
COMMENT     Treatment of urinary incontinence
TARGET      CHRM3 [HSA:1131] [KO:K04131]
  PATHWAY   hsa04020(1131)  Calcium signaling pathway
            hsa04080(1131)  Neuroactive ligand-receptor interaction
            hsa04725(1131)  Cholinergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04B UROLOGICALS
                G04BD Drugs for urinary frequency and incontinence
                 G04BD07 Tolterodine
                  D01148  Tolterodine tartrate (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genitourinary Agents
              Antispasmodics, Urinary
               Cholinergic Muscarinic Antagonists
                Tolterodine
                 D01148  Tolterodine tartrate (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              25  Urogenital and anal organ agents
               259  Miscellaneous
                2590  Miscellaneous
                 D01148  Tolterodine tartrate (JAN/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00480  Tolterodine
                D01148  Tolterodine tartrate
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00480  Tolterodine
                D01148  Tolterodine tartrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00480  Tolterodine
                 D01148  Tolterodine tartrate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                CHRM3
                 D01148  Tolterodine tartrate (JAN/USP) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01148
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01148
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D01148
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00480  Tolterodine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00480  Tolterodine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00480  Tolterodine
DBLINKS     CAS: 124937-52-6
            PubChem: 7848211
            ChEBI: 32245
            LigandBox: D01148
            NIKKAJI: J1.208.248G
ATOM        34
            1   O6a O    22.5567  -17.4447
            2   C6a C    23.7680  -16.7435
            3   C1c C    24.9791  -17.4447
            4   C1c C    26.1905  -16.7435
            5   C6a C    27.4018  -17.4447
            6   O6a O    28.6130  -16.7435
            7   O6a O    23.7680  -15.3410
            8   O1a O    24.9791  -18.8472
            9   O1a O    26.1905  -15.3410
            10  O6a O    27.4018  -18.8472
            11  C1c C     9.8068  -16.8754
            12  N1c N    11.0205  -17.5762
            13  C1b C    12.2344  -16.8754
            14  C1b C    13.4481  -17.5762
            15  C1c C    14.6618  -16.8754
            16  C8y C    15.8756  -17.5762
            17  C8x C    17.0894  -16.8754
            18  C8y C    18.3032  -17.5762
            19  C1a C    19.5170  -16.8754
            20  C1a C     8.5930  -17.5762
            21  C1a C     9.8068  -15.4739
            22  C1c C    11.0205  -18.9775
            23  C1a C     9.7899  -19.6882
            24  C1a C    12.2175  -19.6687
            25  C8y C    14.6618  -15.4740
            26  C8y C    15.8756  -18.9774
            27  C8x C    18.3032  -18.9776
            28  C8x C    17.1102  -19.6905
            29  O1a O    14.6827  -19.6663
            30  C8x C    15.8607  -14.7817
            31  C8x C    15.8606  -13.3802
            32  C8x C    14.6468  -12.6795
            33  C8x C    13.4479  -13.3718
            34  C8x C    13.4480  -14.7733
BOND        34
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     2   7 2
            7     3   8 1 #Up
            8     4   9 1 #Up
            9     5  10 2
            10   11  12 1
            11   12  13 1
            12   13  14 1
            13   15  14 1 #Down
            14   15  16 1
            15   16  17 1
            16   17  18 2
            17   18  19 1
            18   11  20 1
            19   11  21 1
            20   12  22 1
            21   22  23 1
            22   22  24 1
            23   15  25 1
            24   16  26 2
            25   18  27 1
            26   26  28 1
            27   28  27 2
            28   26  29 1
            29   25  30 2
            30   30  31 1
            31   31  32 2
            32   32  33 1
            33   33  34 2
            34   25  34 1
///
